Ethics. Research. Community.

Trial Hints Baxter’s Gammagard Can Slow Alzheimer’s

New York Times. 
[Record Source: New York Times]
Some Alzheimer’s patients who used the therapy, already approved for immune disorders, showed no worsening of symptoms for three years.
Access the full text from your libraries at your institution.  You will be navigating away from EthicShare.

Database Keywords

Detailed Record Information

Record TypeNews/Magazine Article
LicenseNone (All rights reserved) ©